Teva recalls cancer drug Adrucil after rubber particles discovered in vials

Teva Pharmaceutical Industries ($TEVA) is voluntarily recalling 8 lots of Adrucil, its version of the generic cancer treatment fluorouracil. The drugmaker said the recall was initiated after particulate was found in some vials that it identified as an aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals. Recall